General Information of Drug Therapeutic Target (DTT) (ID: TTALN9W)

DTT Name Indoleamine 2,3-dioxygenase 2 (IDO2)
Synonyms Indoleamine-pyrrole 2,3-dioxygenase-like protein 1; Indoleamine 2,3-dioxygenase-like protein 1; INDOL1; IDO-2
Gene Name IDO2
DTT Type
Patented-recorded target
[1]
BioChemical Class
Oxygenase
UniProt ID
I23O2_HUMAN
TTD ID
T62266
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 1.13.11.-
Sequence
MLHFHYYDTSNKIMEPHRPNVKTAVPLSLESYHISEEYGFLLPDSLKELPDHYRPWMEIA
NKLPQLIDAHQLQAHVDKMPLLSCQFLKGHREQRLAHLVLSFLTMGYVWQEGEAQPAEVL
PRNLALPFVEVSRNLGLPPILVHSDLVLTNWTKKDPDGFLEIGNLETIISFPGGESLHGF
ILVTALVEKEAVPGIKALVQATNAILQPNQEALLQALQRLRLSIQDITKTLGQMHDYVDP
DIFYAGIRIFLSGWKDNPAMPAGLMYEGVSQEPLKYSGGSAAQSTVLHAFDEFLGIRHSK
ESGDFLYRMRDYMPPSHKAFIEDIHSAPSLRDYILSSGQDHLLTAYNQCVQALAELRSYH
ITMVTKYLITAAAKAKHGKPNHLPGPPQALKDRGTGGTAVMSFLKSVRDKTLESILHPRG
Function
Involved in immune regulation. May not play a significant role in tryptophan-related tumoral resistance. Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway.
KEGG Pathway
Tryptophan metabolism (hsa00380 )
Metabolic pathways (hsa01100 )
African trypanosomiasis (hsa05143 )
Reactome Pathway
Tryptophan catabolism (R-HSA-71240 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
8 Patented Agent(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
2,3-diamino-benzo[b]thiophene derivative 1 DMD2KRW N. A. N. A. Patented [1]
2,3-diamino-benzo[b]thiophene derivative 2 DMDYXKT N. A. N. A. Patented [1]
2,3-diamino-benzo[b]thiophene derivative 4 DMEDFNC N. A. N. A. Patented [1]
2,3-diamino-benzo[b]thiophene derivative 5 DM05WXD N. A. N. A. Patented [1]
2,3-diamino-benzo[b]thiophene derivative 6 DMINE6V N. A. N. A. Patented [1]
2,3-diamino-benzo[b]thiophene derivative 7 DMQVMNJ N. A. N. A. Patented [1]
2,3-diamino-benzo[b]thiophene derivative 8 DM5O8K0 N. A. N. A. Patented [1]
PMID27172114-Compound-30 DMBWLSA N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Patented Agent(s)

The Drug-Metabolizing Enzyme (DME) Role of This DTT

DTT DME Name Indoleamine 2,3-dioxygenase 2 (IDO2) DME Info
Gene Name IDO2
1 Approved Drug(s) Metabolized by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-Tryptophan DMIBH7M Depression 6A70-6A7Z Approved [2]
------------------------------------------------------------------------------------

References

1 Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):815-32.
2 Kynurenine pathway metabolites and enzymes involved in redox reactions. Neuropharmacology. 2017 Jan;112(Pt B):331-345.